MedPath

VISUFARMA SPA

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.visufarma.it

The Usefulness of Visuprime in Cataract Surgery

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: Visuprime
Other: Placebo
First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
VISUfarma SpA
Target Recruit Count
75
Registration Number
NCT06533995
Locations
🇮🇹

Clinica Fabia Mater, Rome, RM, Italy

🇮🇹

Policlinico Casilino, Rome, RM, Italy

VISUPRIME® Eye Drops

Not Applicable
Completed
Conditions
Proliferative Diabetic Retinopathy
Diabetic Macular Edema
Macular Edema of Right Retina (Diagnosis)
Macular Degeneration, Age Related
Myopic Choroidal Neovascularisation
Interventions
Device: VISUPRIME
Device: Placebo
First Posted Date
2023-01-10
Last Posted Date
2024-07-19
Lead Sponsor
VISUfarma SpA
Target Recruit Count
78
Registration Number
NCT05677685
Locations
🇮🇹

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, BA, Italy

🇮🇹

Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, TS, Italy

🇮🇹

Ospedale Santa Maria della Misericordia, Perugia, PG, Italy

and more 3 locations

Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

Not Applicable
Conditions
Dry Eye Syndromes
Interventions
Device: VisuXL® Gel
Device: HYLO®
First Posted Date
2020-07-24
Last Posted Date
2020-07-24
Lead Sponsor
VISUfarma SpA
Target Recruit Count
90
Registration Number
NCT04485533
Locations
🇫🇷

Hôpital Morvan, Brest, Finistère, France

🇪🇸

Hospital Clínico San Carlos de Madrid, Madrid, Spain

🇮🇹

ASST-Santi Paolo e Carlo-Presidio San Paolo, Milano, MI, Italy

Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD

Conditions
AMD
Interventions
Dietary Supplement: Visucomplex Plus
First Posted Date
2019-11-26
Last Posted Date
2020-04-27
Lead Sponsor
VISUfarma SpA
Target Recruit Count
160
Registration Number
NCT04177069
Locations
🇮🇹

Ospedale Felice Lotti, Pontedera, Pisa, Italy

🇮🇹

ASST Spedali Civili di Brescia, Brescia, Italy

🇮🇹

Casa di Cura Villa dei Fiori, Acerra, Napoli, Italy

and more 1 locations

Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma

Not Applicable
Conditions
Glaucoma, Open-Angle
Interventions
Dietary Supplement: Placebo
Dietary Supplement: CoQ10- MINIACTIVES
First Posted Date
2019-07-30
Last Posted Date
2020-04-28
Lead Sponsor
VISUfarma SpA
Target Recruit Count
70
Registration Number
NCT04038034
Locations
🇮🇹

UO Oculistica - PO Cisanello, Pisa, PI, Italy

🇮🇹

U.O. di Oculistica, Fondazione Policlinico Agostino A. Gemelli,, Rome, Italy

Evaluation of the VisuXL® Performance on Ocular Surface Discomfort

Not Applicable
Completed
Conditions
Ocular Discomfort
Interventions
Device: VisuXL®
First Posted Date
2019-02-18
Last Posted Date
2019-02-18
Lead Sponsor
VISUfarma SpA
Target Recruit Count
20
Registration Number
NCT03844737
Locations
🇮🇹

UO Oculistica, Fondazione Policlinico Universitario A. Gemelli, Roma, Italy

Evaluation of MAF-1217 in Patients With DED

Not Applicable
Completed
Conditions
Evaporative Dry Eye Disease
Interventions
Device: MAF1217
Other: Cationorm
First Posted Date
2019-02-07
Last Posted Date
2019-07-15
Lead Sponsor
VISUfarma SpA
Target Recruit Count
72
Registration Number
NCT03833882
Locations
🇮🇹

Ospedale San Paolo, ASST Santi Paolo e Carlo, Milan, Italy

🇮🇹

ASST Fatebenefratelli Sacco P.O.L. Sacco, Milan, Italy

Evaluation of the Performance of MAF-1217 on Cataract Surgery

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Device: MAF-1217
First Posted Date
2019-02-07
Last Posted Date
2019-07-15
Lead Sponsor
VISUfarma SpA
Target Recruit Count
46
Registration Number
NCT03833908
Locations
🇮🇹

Università di Firenze, Clinica Oculistica II,, Firenze, Italy

🇮🇹

Ospedale San Paolo, ASST Santi Paolo e Carlo, Milan, Italy

Bioavailability Study of COQUN ORAL FORMULATION

Phase 1
Completed
Conditions
Male & Female Healthy Volunteers
Interventions
Dietary Supplement: COQUN ORAL FORMULATION
First Posted Date
2019-01-28
Last Posted Date
2019-09-06
Lead Sponsor
VISUfarma SpA
Target Recruit Count
24
Registration Number
NCT03819491
Locations
🇷🇴

Consult Med Iasi, Iasi, Iasi County, Romania, Romania

© Copyright 2025. All Rights Reserved by MedPath